{"public_id":"co_b681df956fe9aab9627ca3387def35e4","status":"active","merged_into_public_id":null,"resolved_public_id":"co_b681df956fe9aab9627ca3387def35e4","name":"cost-effectiveness","description":"An economic evaluation of outcomes relative to costs.","aliases":[],"types":["economic outcome"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":72940547,"title":"Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial","citation_count":417,"url":"https://sah.borca.ai/papers/72940547"}],"claims":[{"public_id":"cl_bbc83ded3fae27925c62c35fed3cd4f2","text":"From an ophthalmology cost perspective, selective laser trabeculoplasty first had a 97% probability of being more cost-effective than eye drops first at a willingness to pay of £20,000 per quality-adjusted life-year gained.","corpus_id":72940547,"url":"https://sah.borca.ai/claims/cl_bbc83ded3fae27925c62c35fed3cd4f2"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_b681df956fe9aab9627ca3387def35e4","url":"https://sah.borca.ai/concepts/co_b681df956fe9aab9627ca3387def35e4"}